Stocklytics Platform
Asset logo for symbol RXST
RxSight
RXST67
$47.72arrow_drop_down4.13%-$2.06
High Growth
Asset logo for symbol RXST
RXST67

$47.72

arrow_drop_down4.13%

Performance History

Chart placeholder
Key Stats
Open$50.39
Prev. Close$49.78
EPS-1.24
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
Market Cap$1.95B
PE Ratio-
LOWHIGH
Day Range45.50
51.30
52 Week Range20.66
66.54
Ratios
P/B Ratio11.92
Revenue$89.07M
Operating M. %-36.15%
Earnings$0.00
Earnings Growth %27.19%
EBITDA Margin %-48.74%
ROE %-28.81%
EPS-1.24

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

Correlated Companies

Price$948.40
Perf. (24h)
arrow_drop_up1.52%$14.26
Market Cap$841.10B
Price$511.53
Perf. (24h)
arrow_drop_up1.42%$7.17
Market Cap$464.20B
Price$149.88
Perf. (24h)
arrow_drop_up0.12%$0.18
Market Cap$360.27B
Price$127.76
Perf. (24h)
arrow_drop_down0.93%-$1.21
Market Cap$326.65B

About RxSight (RXST)

RxSight, Inc., an ophthalmic medical device company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. It primarily serves cataract doctors. The company was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. RxSight, Inc. was incorporated in 1997 and is headquartered in Aliso Viejo, California.

Sector
Healthcare
Industry
Medical Devices
CEO
Dr. Ronald M. Kurtz M.D.
Headquarters
Aliso Viejo
Employees
292
Exchange
NASDAQ
add RxSight to watchlist

Keep an eye on RxSight

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help
What is RxSight's (RXST) price per share?

The current price per share for RxSight (RXST) is $47.72. The stock has seen a price change of -$2.06 recently, indicating a -4.14% change. This reflects the stock's recent market performance and investor sentiment.

help
What is the 52-week high and low for RxSight (RXST)?

For RxSight (RXST), the 52-week high is $66.54, which is 39.44% from the current price. The 52-week low is $20.66, the current price is 130.98% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help
Is RxSight (RXST) a growth stock?

RxSight (RXST) has shown an average price growth of 0.41% over the past three years. It has received a score of 96 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying RxSight as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help
What is RxSight (RXST) stock price performance year to date (YTD)?

As of the latest data, RxSight (RXST) has a year-to-date price change of 30.2%. Over the past month, the stock has experienced a price change of -19.58%. Over the last three months, the change has been -10.4%. Over the past six months, the figure is 5.27%.

help
Is RxSight (RXST) a profitable company?

RxSight (RXST) has a net income of -$48.61M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 60.36% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -36.15% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $89.08M, with a revenue growth rate of 81.77%, providing insight into the company's sales performance and growth. The gross profit is $53.76M. Operating income is noted at -$50.08M. Furthermore, the EBITDA is -$43.42M.

help
What is the market capitalization of RxSight (RXST)?

RxSight (RXST) has a market capitalization of $1.95B. The average daily trading volume is 736.29K, indicating the stock's liquidity and investor engagement.

News

email

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Take Your Investments to a Whole New Level